ASLN
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN
Delisted
ASLN was delisted on the 18th of July, 2024.
41 hedge funds and large institutions have $88.7M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+29
Holders Change %
+241.67%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
5
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RI
RTW Investments
New York
|
$10.9M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
$9.52M |
| 3 |
O
OrbiMed
New York
|
$8.44M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
$7.71M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
$7.3M |
Top Sellers
| 1 |
BFM
Boothbay Fund Management
New York
|
$439K |
| 2 |
Renaissance Technologies
New York
|
$866K |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
$243K |
| 4 |
Morgan Stanley
New York
|
$148K |
| 5 |
UBS Group
Zurich,
Switzerland
|
$2K |
